Columbia scientists develop world’s first prototype ‘Universal Antiviral’
Published on: Aug. 20, 2025, 5:19 a.m. | Source: Economic Times
Scientists at Columbia University are developing a universal antiviral. This treatment aims to protect against many viruses, including influenza and COVID-19. The therapy is inspired by a rare genetic mutation. It uses mRNA technology to produce antiviral proteins. Tests on mice and hamsters show reduced viral replication. This offers short-term protection during outbreaks.
